1
EXHIBIT 10.27(b)
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
SECOND AMENDMENT
TO
STOCK PURCHASE AGREEMENT
This Second Amendment (the "Amendment") dated as of February ___, 1998
to the Stock Purchase Agreement (the "Purchase Agreement") dated as of August
25, 1997, as amended on November 26, 1997, by and among Hoechst Xxxxxx Xxxxxxx,
Inc., a Delaware corporation ("Parent"), Marisub, Inc., a Delaware corporation
and the wholly-owned subsidiary of Parent ("Seller"), and Xxxxxx
Pharmaceuticals, Inc., a Nevada corporation ("Xxxxxx"), is entered into by and
among Xxxxxx, Parent and Seller.
RECITALS
X. Xxxxxx, Parent and Seller have heretofore entered into the Purchase
Agreement, which provides, among other things, for the acquisition by Xxxxxx of
all the outstanding capital stock of The Rugby Group, Inc. (the "Company"). All
capitalized terms used herein and not otherwise defined herein shall have the
meanings ascribed to them in the Purchase Agreement.
X. Xxxxxx, Parent and Seller wish to enter into this Amendment to amend
certain provisions and exhibits of the Purchase Agreement.
AGREEMENTS
NOW THEREFORE, in consideration of the premises and mutual agreements
herein contained, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereto agree as
follows:
1. Status of Purchase Agreement. Except as specifically set forth
herein, the Purchase Agreement and each of the exhibits thereto shall remain in
full force and effect and shall not be waived, modified, superseded or otherwise
affected by this Amendment. This Amendment is not to be construed as a release,
waiver or modification of any of the terms, conditions, representations,
warranties, covenants, rights or remedies set forth in the Purchase Agreement,
except as specifically set forth herein.
2. Amendments to the Purchase Agreement.
2.1 Recital A of the Purchase Agreement. Recital A of the Purchase
Agreement is hereby deleted in its entirety and replaced with the following:
"A. Seller owns all of the outstanding shares of capital stock
("Shares") of The Rugby Group, Inc., a New York corporation (the "Company"),
which Shares consist of 220 shares of common stock."
2.2 Section 3.2(a) of the Purchase Agreement. Section 3.2(a) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
2
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
"(a) The total authorized capital stock of the Company consists of (i)
400 shares of common stock, par value $50 per share, 220 shares of which are
issued and outstanding as of the date of this Agreement; (ii) 20,000 shares of
first preferred stock, par value $1 per share, no shares of which are issued and
outstanding as of the date of this Agreement; and (iii) 2,400 shares of second
preferred stock, par value $1,000 per share, no shares of which are issued and
outstanding as of the date of this Agreement. There are no shares of capital
stock of the Company of any other class authorized, issued or outstanding."
2.3 Section 5.1(e) of the Purchase Agreement. Section 5.1(e) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
"(e) The Company and Parent shall have entered into the side letter
relating to * in the form attached hereto as Exhibit A."
2.4 Section 5.1(f) of the Purchase Agreement. Section 5.1(f) of the
Purchase Agreement is hereby amended such that the form of Contract
Manufacturing Agreement attached to the Agreement as Exhibit B shall be revised
as set forth in Annex A attached hereto.
2.5 Section 5.1(g) of the Purchase Agreement. Section 5.1(g) of the
Purchase Agreement is hereby amended such that the form of Agreement with
Respect to Tax Matters attached to the Agreement as Exhibit C shall be revised
as set forth in Annex B attached hereto.
2.6 Section 5.1(h) of the Purchase Agreement. Section 5.1(h) of the
Purchase Agreement is hereby amended such that the form of Supply and License
Agreement attached to the Agreement as Exhibit D shall be revised as set forth
in Annex C attached hereto.
2.7 Section 5.1(i) of the Purchase Agreement. Section 5.1(i) of the
Purchase Agreement is hereby amended such that the form of Lease attached to the
Agreement as Exhibit E shall be revised as set forth in Annex D attached hereto.
2.8 Section 5.1(j) of the Purchase Agreement. Section 5.1(j) of the
Purchase Agreement is hereby amended such that the form of Information Services
Agreement attached to the Agreement as Exhibit F shall be revised as set forth
in Annex E attached hereto.
2.9 Section 5.1(k) of the Purchase Agreement. Section 5.1(k) of the
Purchase Agreement is hereby amended such that the form of Seconding Agreement
attached to the Agreement as Exhibit G shall be revised as set forth in Annex F
attached hereto.
2.10 Section 5.1(l) of the Purchase Agreement. A new Section 5.1(l) is
hereby added to the Purchase Agreement to read as follows:
"(l) Xxxxxx and HMRI shall have entered into the letter agreement
relating to *, attached to this Amendment as Annex G."
2.11 Section 5.3(i) of the Purchase Agreement. Section 5.3(i) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
2
3
"(i) Intentionally omitted."
2.12 Section 5.3(j) of the Purchase Agreement. Section 5.3(j) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
"(j) Xxxxxx shall have received a letter from Parent stating
that the intercompany payable owed by the Company and/or its Subsidiaries to
Parent and/or its affiliates has been converted from a liability to a
contribution of capital by Parent to Seller and by Seller to the Company as of
the Closing Date;"
2.13 Section 5.3(l) of the Purchase Agreement. Section 5.3(l) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
"(l) Intentionally omitted."
2.14 Section 6.2(b) of the Purchase Agreement. Section 6.2 of the
Purchase Agreement is hereby amended by deleting the word "During" and replacing
such word with the phrase "From and after the Closing, during".
2.15 Section 6.3 of the Purchase Agreement. Section 6.3 of the Purchase
Agreement is hereby amended by deleting the word "Novopharm" and replacing such
word with the phrase "Novopharm Limited ("Novopharm")".
2.16 Section 6.6(a) of the Purchase Agreement. Section 6.6(a) of the
Purchase Agreement is hereby deleted in its entirety and replaced with the
following:
"(a) Except for acquisitions which qualify for the treatment under
Section 6.6(b) herein: if, at any time prior to January 1, 2000, (i) Xxxxxx or
any of its Subsidiaries (A)(I) acquires any pharmaceutical distribution business
or any portion thereof in one or a series of related transactions; or (II)
acquires any entity which is in the pharmaceutical distribution business in one
or a series of related transactions and such distribution business is acquired
by Xxxxxx or any of its Subsidiaries in connection with such acquisition, and,
in each of (I) or (II) above, the aggregate net sales of the distribution
business acquired exceeds $* during the twelve month period immediately prior to
such acquisition, excluding the net sales of any products acquired which are or
will be Xxxxxx Products; or (ii) Xxxxxx sells to an unaffiliated third party all
or substantially all of the Distribution Business in one or a series of related
transactions (each of (i) and (ii) being collectively referred to herein as a
"Sale Event"), then, except as provided below in this Section 6.6(a), for
purposes of calculating the Upside Net Profit, the Distribution Net Profits
derived by Xxxxxx and its Subsidiaries from the Distribution Business during
calendar year 1999 shall be deemed to be equal to the Distribution Net Profits
derived by Xxxxxx and its Subsidiaries from the Distribution Business during the
twelve month period ending on the last day of the calendar month immediately
preceding such Sale Event. Notwithstanding the foregoing, if the net profits
(calculated in the same manner as the calculation of Distribution Net Profits)
of any distribution business acquired by Xxxxxx or any of its Subsidiaries
pursuant to Section 6.6(a)(i) is not less than zero for the twelve month period
ending on the date of the most recent financial statements referenced in the
principal acquisition agreement relating to Xxxxxx'x or any of its Subsidiaries'
acquisition of such distribution business, then, in lieu of the foregoing
calculation of Distribution Net Profits, Xxxxxx may, in its sole discretion,
elect to calculate Distribution Net Profits derived by Xxxxxx and its
Subsidiaries from the Distribution Business
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
3
4
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
during calendar year 1999 in accordance with the provisions of Section 6.5
hereof. Xxxxxx must exercise such election by delivering written notice to
Parent on or prior to the closing date of the acquisition of such distribution
business. If Xxxxxx or one of its Subsidiaries acquires any entity described in
Section 6.6(a)(i)(A) above, with net sales (excluding sales attributable to
Xxxxxx Products) equal to or less than $* during the twelve month period
immediately prior to such acquisition, the net profits (calculated in the same
manner as the calculation of Distribution Net Profits) derived by Xxxxxx and its
Subsidiaries from such acquired business during calendar year 1999 shall be
included in the calculation of Distribution Net Profits."
2.17 Article VI of the Purchase Agreement. Article VI of the Purchase
Agreement is hereby amended by adding the following to the end of such article:
"6.18 Severance Benefits.
(a) To the extent that the Company or any of its Subsidiaries incur any
severance obligations or liabilities which exceed * in connection with the
Company's and its Subsidiaries' anticipated plant closings at their facilities
located in *, whether before or after Closing, Parent shall reimburse the
Company for any such excess as soon as practicable after the amount of such
excess is determined.
(b) To the extent the Company or any of its Subsidiaries pays any
severance obligations or liabilities prior to the Closing to any employee in
connection with the Company's and its Subsidiaries' anticipated plant closings
at their facilities located in *, Xxxxxx agrees to reimburse the Company for the
amount of any such payments made to any such employee up to the amount of * with
respect to each such employee. Such payments shall be made by Xxxxxx to the
Company as soon as practicable after the amount of such severance obligation or
liability has been paid by the Company and invoiced to Xxxxxx.
(c) After the Closing, to the extent that any employee of the Company
or any of its Subsidiaries claims to have a right to severance benefits in
excess of * due to actions taken by the Company or its Subsidiaries at any time
prior to the Closing Date with respect to the closings of its facilities located
in *, Parent agrees to indemnify and hold harmless Xxxxxx, the Company and each
of its Subsidiaries for (a) all costs and expenses, including, without
limitation, reasonable attorneys fees, incurred by Xxxxxx, the Company or any of
its Subsidiaries in connection with the defense or investigation of any such
claim; and (b) all severance benefits paid to any such employee in excess of *.
Notwithstanding the foregoing, Xxxxxx agrees that Parent shall not have any
indemnification obligations under this Section 6.18(c) unless such severance
payments were made by Xxxxxx or its Subsidiaries pursuant to either (i) Parent's
prior written consent, which consent shall not be unreasonably withheld, or (ii)
a direction to make any such payment by a competent authority."
2.18 Section 7.5(d) of the Purchase Agreement. Section 7.5(d) of the
Purchase Agreement is hereby amended by deleting the phrase "Section 7.3(c)
hereof" and inserting in its place the following: "(a) Section 7.3(c); or (b) a
violation by Parent of its obligations contained in Section 6.18 of this
Agreement,"
2.19 Section 8.2 of the Purchase Agreement. Section 8.2 of the Purchase
Agreement is hereby amended by deleting the date "December 15, 1997" contained
in such section and replacing such date with "February 27, 1998".
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
4
5
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
3. Disclosure Statement. The Disclosure Statement is hereby amended to
add the matters set forth on Annex H attached hereto.
4. Representations and Warranties of Entities. Each of Xxxxxx, Parent
and Seller represents and warrants that its execution, delivery and performance
of this Amendment has been duly authorized by all necessary corporate action and
this Amendment is a legal, valid and binding obligation of such entity in
accordance with its terms.
5. Counterparts. This Amendment may be executed in any number of
counterparts, each of which shall be deemed an original and all of which
together shall constitute one and the same instrument.
6. Governing Law. This Amendment shall be a contract made under and
governed by the laws of the State of New York, without regard to conflict of
laws principles.
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
5
6
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
IN WITNESS WHEREOF, the parties have executed this Amendment and caused
the same to be duly delivered on their behalf on the day and year first written
above.
XXXXXX PHARMACEUTICALS, INC.
By:
---------------------------------
Title:
------------------------------
HOECHST XXXXXX XXXXXXX, INC.
By:
---------------------------------
Title:
------------------------------
MARISUB, INC.
By:
---------------------------------
Title:
------------------------------
CONFIDENTIAL TREATMENT - NOTED BY * AND STRIKE-THROUGH
6
